# LITHIUM CITRATE
> **ANDA070755** · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS PHARM · Approved 1986-05-21
## Drug
- **FDA Application Number:** ANDA070755
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LITHIUM CITRATE
- **Generic name:** LITHIUM
- **Active ingredients:** LITHIUM CITRATE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PAI HOLDINGS PHARM
- **Manufacturer:** PAI Holdings, LLC dba PAI Pharma
- **First approval:** 1986-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070755)
---
*MORVS · CC0 1.0*